pharmaceutical investing Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
EnerCom Announces Initial List of Presenting Companies for the 31st Annual Energy Investment Conference to be held August 17-19, 2026, in Denver, Colorado
